<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Pricing information, etc., required by regulations</p><ul class="Section ProvisionList" id="413386"><li><p class="Subsection" id="413388"><strong><a class="sectionLabel" id="s-80"><span class="sectionLabel">80</span></a></strong> <span class="lawlabel">(1)</span> A rights holder for an invention pertaining to a medicine shall, as required by and in accordance with the regulations, provide the Board with the information and documents that the regulations may specify respecting</p><ul class="ProvisionList"><li><p class="Paragraph" id="413389"><span class="lawlabel">(a)</span> the identity of the medicine;</p></li><li><p class="Paragraph" id="413390"><span class="lawlabel">(b)</span> the price at which the medicine is being or has been sold in any market in Canada and elsewhere;</p></li><li><p class="Paragraph" id="1309659"><span class="lawlabel">(c)</span> the costs of making and marketing the medicine, if that information is available to the rights holder in Canada or is within the knowledge or control of the rights holder;</p></li><li><p class="Paragraph" id="413392"><span class="lawlabel">(d)</span> the factors referred to in section 85; and</p></li><li><p class="Paragraph" id="413393"><span class="lawlabel">(e)</span> any other related matters.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Former rights holder</p><p class="Subsection" id="413394"><span class="lawlabel">(2)</span> Subject to subsection (3), a person who is a former rights holder for an invention pertaining to a medicine shall, as required by and in accordance with the regulations, provide the Board with the information and documents that the regulations may specify respecting</p><ul class="ProvisionList"><li><p class="Paragraph" id="413396"><span class="lawlabel">(a)</span> the identity of the medicine;</p></li><li><p class="Paragraph" id="1309662"><span class="lawlabel">(b)</span> the price at which the medicine was sold in any market in Canada and elsewhere during the period in which the person was a rights holder for the invention;</p></li><li><p class="Paragraph" id="1309663"><span class="lawlabel">(c)</span> the costs of making and marketing the medicine produced during that period, whether incurred before or after the patent was issued or the certificate of supplementary protection took effect, if that information is available to the person in Canada or is within the knowledge or control of the person;</p></li><li><p class="Paragraph" id="413399"><span class="lawlabel">(d)</span> the factors referred to in section 85; and</p></li><li><p class="Paragraph" id="413400"><span class="lawlabel">(e)</span> any other related matters.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Limitation</p><p class="Subsection" id="1309664"><span class="lawlabel">(3)</span> Subsection (2) does not apply to a person who has not, for a period of three or more years, been entitled to the benefit of the patent or certificate of supplementary protection, as the case may be, or to exercise any rights in relation to the patent or certificate.</p></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">1993, c. 2, s. 7</li><li class="HistoricalNoteSubItem"><a href="#1036460-1309666" aria-controls="centred-popup" class="wb-lbx" role="button" data-ajax-after="1036460-1309666.html">2017, c. 6, s. 47</a></li></ul></div>
<div class="PITLink"><a class="PITLink" href="section-80-20021231.html" title="Link to previous version of section 80">Previous Version</a></div>
